Effects of Treadmill Training and Whole-body Vibration in Children With Cerebral Palsy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-17
SponsorGeorgia State University

About this trial

Whole-body vibration (WBV) and treadmill training (TT) are commonly-utilized rehabilitation interventions for children with neuromotor disorders. WBV has been shown in the literature to positively affect gait and lower body spasticity in this population. However, the effects of a single session of WBV are generally transient, lasting between ten minutes and two hours. Thus, it may be necessary to combine WBV with another intervention to reinforce improved movement patterns and maximize its potential benefits. Therefore, the aim of this study is to investigate the effects of the addition of a single bout of WBV to a single bout of TT on the lower extremity spasticity and gait parameters of ambulatory children with CP.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

a medical diagnosis of spastic CP

a GMFCS level of I, II, or III

age of 6-17 years at the time of data collection

Disqualifiers

history of musculoskeletal injury within the past 3 months

history of Botox injections to the lower extremities within the past 3 months

history of significant cardiac abnormalities and/or uncontrolled seizures

any cognitive or behavioral issues that prevent the subject from safely following instructions while walking on the treadmill

Trial design

Design model

Single group

Treatments tested in this trial

  • Treadmill Training

    Other intervention

    Ten minutes of treadmill walking at 110% self-selected overground walking speed

  • Whole Body Vibration & Treadmill Training

    Other intervention

    Eight bouts of 90 seconds of vibration at 20 Hz and an amplitude of 2 mm on a Galileo Med-L side-to-side-alternating WBV plate (StimDesigns LLC, Carmel, CA, USA) followed by ten minutes of treadmill walking at 110% self selected overground walking speed.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Intervention GroupExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Overground gait walking speed

Measured in m/s from kinematic motion capture data

Time frame
immediately after intervention
2

Overground gait step length

Measured in cm from kinematic motion capture data

Time frame
immediately after intervention
3

Overground gait dynamic knee range of motion

Measured in degrees from kinematic motion capture data

Time frame
immediately after intervention
4

Overground gait dynamic ankle range of motion

Measured in degrees from kinematic motion capture data

Time frame
immediately after intervention

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.